OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The current understanding on the impact of KRAS on colorectal cancer
Mingjing Meng, Keying Zhong, Ting Jiang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111717-111717
Open Access | Times Cited: 122
Mingjing Meng, Keying Zhong, Ting Jiang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111717-111717
Open Access | Times Cited: 122
Showing 1-25 of 122 citing articles:
Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
E O'Sullivan, Anna Keogh, Brian E. Henderson, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1635-1635
Open Access | Times Cited: 47
E O'Sullivan, Anna Keogh, Brian E. Henderson, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1635-1635
Open Access | Times Cited: 47
Unveiling the role of KRAS in tumor immune microenvironment
Miao Xu, Xing Zhao, Ti Wen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116058-116058
Open Access | Times Cited: 29
Miao Xu, Xing Zhao, Ti Wen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116058-116058
Open Access | Times Cited: 29
Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment
William H. Gmeiner
Cancers (2024) Vol. 16, Iss. 5, pp. 1029-1029
Open Access | Times Cited: 19
William H. Gmeiner
Cancers (2024) Vol. 16, Iss. 5, pp. 1029-1029
Open Access | Times Cited: 19
Targeting the RAS upstream and downstream signaling pathway for Cancer treatment
Md. Arafat Hossain
European Journal of Pharmacology (2024) Vol. 979, pp. 176727-176727
Closed Access | Times Cited: 15
Md. Arafat Hossain
European Journal of Pharmacology (2024) Vol. 979, pp. 176727-176727
Closed Access | Times Cited: 15
Effect of Drying Methods on the Phenolic Profile and Antioxidant Capacity of Pithecellobium dulce (Roxb.) Benth. Aril and Its Inhibitory Properties on Human SW480 Colon Adenocarcinoma Cells
Ángel Félix Vargas-Madriz, Aarón Kuri-García, Iván Luzardo‐Ocampo, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 233-233
Open Access | Times Cited: 1
Ángel Félix Vargas-Madriz, Aarón Kuri-García, Iván Luzardo‐Ocampo, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 233-233
Open Access | Times Cited: 1
Molecular Complexity of Colorectal Cancer: Pathways, Biomarkers, and Therapeutic Strategies
Zhengdong Yang, Xinyang Wang, Huiying Zhou, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 1389-1403
Open Access | Times Cited: 8
Zhengdong Yang, Xinyang Wang, Huiying Zhou, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 1389-1403
Open Access | Times Cited: 8
In Silico Prediction of New Inhibitors for Kirsten Rat Sarcoma G12D Cancer Drug Target Using Machine Learning-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulation Approaches
Amar Ajmal, Muhammad Danial, Maryam Zulfat, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 551-551
Open Access | Times Cited: 7
Amar Ajmal, Muhammad Danial, Maryam Zulfat, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 551-551
Open Access | Times Cited: 7
Citrus limon L.-Derived Nanovesicles Show an Inhibitory Effect on Cell Growth in p53-Inactivated Colorectal Cancer Cells via the Macropinocytosis Pathway
Hideki Takakura, Toshimasa Nakao, Takumi Narita, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1352-1352
Open Access | Times Cited: 28
Hideki Takakura, Toshimasa Nakao, Takumi Narita, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1352-1352
Open Access | Times Cited: 28
Mutant RAS and the tumor microenvironment as dual therapeutic targets for advanced colorectal cancer
Jorien B.E. Janssen, Jan Paul Medema, Elske C. Gootjes, et al.
Cancer Treatment Reviews (2022) Vol. 109, pp. 102433-102433
Open Access | Times Cited: 27
Jorien B.E. Janssen, Jan Paul Medema, Elske C. Gootjes, et al.
Cancer Treatment Reviews (2022) Vol. 109, pp. 102433-102433
Open Access | Times Cited: 27
Cell phenotypes can be predicted from propensities of protein conformations
Ruth Nussinov, Yonglan Liu, Wengang Zhang, et al.
Current Opinion in Structural Biology (2023) Vol. 83, pp. 102722-102722
Open Access | Times Cited: 16
Ruth Nussinov, Yonglan Liu, Wengang Zhang, et al.
Current Opinion in Structural Biology (2023) Vol. 83, pp. 102722-102722
Open Access | Times Cited: 16
Therapeutic and diagnostic applications of exosomes in colorectal cancer
Neda Shakerian, Elham Darzi-Eslam, Fatemeh Afsharnoori, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access | Times Cited: 5
Neda Shakerian, Elham Darzi-Eslam, Fatemeh Afsharnoori, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access | Times Cited: 5
Recent Advances in the Study of Extracellular Vesicles in Colorectal Cancer
Sarah E. Glass, Robert J. Coffey
Gastroenterology (2022) Vol. 163, Iss. 5, pp. 1188-1197
Open Access | Times Cited: 22
Sarah E. Glass, Robert J. Coffey
Gastroenterology (2022) Vol. 163, Iss. 5, pp. 1188-1197
Open Access | Times Cited: 22
Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal Cancer
Stefania Napolitano, Melanie Woods, Hey Min Lee, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 12, pp. 2299-2309
Open Access | Times Cited: 11
Stefania Napolitano, Melanie Woods, Hey Min Lee, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 12, pp. 2299-2309
Open Access | Times Cited: 11
Factors Affecting Variation of the Human Gut Phageome
Ciara A. Tobin, Colin Hill, Andrey N. Shkoporov
Annual Review of Microbiology (2023) Vol. 77, Iss. 1, pp. 363-379
Closed Access | Times Cited: 11
Ciara A. Tobin, Colin Hill, Andrey N. Shkoporov
Annual Review of Microbiology (2023) Vol. 77, Iss. 1, pp. 363-379
Closed Access | Times Cited: 11
A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance
Anggraeni Endah Kusumaningrum, Sarce Makaba, Eyhab Ali, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 4
Anggraeni Endah Kusumaningrum, Sarce Makaba, Eyhab Ali, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 4
Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial
Josep Tabernero, Julien Taı̈eb, Marwan Fakih, et al.
ESMO Open (2024) Vol. 9, Iss. 3, pp. 102945-102945
Open Access | Times Cited: 4
Josep Tabernero, Julien Taı̈eb, Marwan Fakih, et al.
ESMO Open (2024) Vol. 9, Iss. 3, pp. 102945-102945
Open Access | Times Cited: 4
Targeting KRAS G12C and G12S Mutations in Lung Cancer: In Silico Drug Repurposing and Antiproliferative Assessment on A549 Cells
Mansour S. Alturki, Nada Tawfeeq, Amal Alissa, et al.
Informatics in Medicine Unlocked (2025), pp. 101612-101612
Open Access
Mansour S. Alturki, Nada Tawfeeq, Amal Alissa, et al.
Informatics in Medicine Unlocked (2025), pp. 101612-101612
Open Access
Oncoproteins E6/E7 of the human papillomavirus types 16 & 18 synergize in modulating oncogenes and tumor suppressor proteins in colorectal cancer
Queenie Fernandes, Lubna Therachiyil, Shahd M. Younis, et al.
Expert Review of Proteomics (2025)
Closed Access
Queenie Fernandes, Lubna Therachiyil, Shahd M. Younis, et al.
Expert Review of Proteomics (2025)
Closed Access
Promising Cellular Immunotherapy for Colorectal Cancer Using Classical Dendritic Cells and Natural Killer T Cells
Mahmoud Singer, Jennifer Valerin, Zhuoli Zhang, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 166-166
Open Access
Mahmoud Singer, Jennifer Valerin, Zhuoli Zhang, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 166-166
Open Access
Intraneoplastic fungal dysbiosis is associated with colorectal cancer progression and host gene mutation
Kai Yuan, Hongzhi Xu, Shengmian Li, et al.
EBioMedicine (2025) Vol. 113, pp. 105608-105608
Closed Access
Kai Yuan, Hongzhi Xu, Shengmian Li, et al.
EBioMedicine (2025) Vol. 113, pp. 105608-105608
Closed Access
Prognostic gene expression profile of colorectal cancer
Mohamed J. Saadh, Omer Qutaiba B. Allela, Radhwan Abdul Kareem, et al.
Gene (2025), pp. 149433-149433
Closed Access
Mohamed J. Saadh, Omer Qutaiba B. Allela, Radhwan Abdul Kareem, et al.
Gene (2025), pp. 149433-149433
Closed Access
Evolution of computational techniques against various KRAS mutants in search for therapeutic drugs: a review article
Asif Mehmood, Mohammed Ageeli Hakami, Hanan A. Ogaly, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Closed Access
Asif Mehmood, Mohammed Ageeli Hakami, Hanan A. Ogaly, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Closed Access
Mechanism of Action and Research Progress of Drugs Targeting KRAS G12-Mutant Tumors
金蓉 郑
World Journal of Cancer Research (2025) Vol. 15, Iss. 02, pp. 77-89
Closed Access
金蓉 郑
World Journal of Cancer Research (2025) Vol. 15, Iss. 02, pp. 77-89
Closed Access
Deep learning based radiomics for gastrointestinal cancer diagnosis and treatment: A minireview
Pak Kin Wong, In Neng Chan, H. J. Yan, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 45, pp. 6363-6379
Open Access | Times Cited: 18
Pak Kin Wong, In Neng Chan, H. J. Yan, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 45, pp. 6363-6379
Open Access | Times Cited: 18
Combination of artesunate and WNT974 induces KRAS protein degradation by upregulating E3 ligase ANACP2 and β-TrCP in the ubiquitin–proteasome pathway
Rui‐Hong Gong, Minting Chen, Chunhua Huang, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 17
Rui‐Hong Gong, Minting Chen, Chunhua Huang, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 17
